Travacom Post Marketing Surveillance Study

Summary

The purpose of this multi-center, open label, single arm, post-marketing surveillance study is to assess the safety of Travacom in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins, or other intraocular pressure-lowering (IOP) medication and when use of Travacom is considered appropriate.

Timeline

Start

2012-01

Primary completion

2012-01

Completion

2012-01

Drugs

Indications